Lv26
166 积分 2021-08-08 加入
Lost in translation: rethinking animal models of progressive MS (an industry perspective)
2天前
求助中
JAK/STAT signalling pathway is involved in the immune mechanism of Bullous pemphigoid
12天前
已完结
Tissue-resident memory CD4 + T cells infiltrate the CNS in progressive multiple sclerosis and contribute to chronic autoimmunity in mice
16天前
已完结
Use of pharmacokinetic versus pharmacodynamic endpoints to support human dose predictions: implications for rational drug design and early clinical development
18天前
已完结
Safety and efficacy of fenebrutinib in relapsing multiple sclerosis (FENopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension study
19天前
已完结
Evobrutinib in multiple sclerosis: challenges and unmet goals
26天前
已完结
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials
26天前
已完结
Evobrutinib in multiple sclerosis: challenges and unmet goals
26天前
已关闭
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
26天前
已完结
Why do IL-17-targeted therapies have limited efficacy?
27天前
已完结
皖公网安备34019202002308
